Aurobindo Pharma Ltd

NSE:AUROPHARMA

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AUROPHARMA's stock price target?

Price Target

1 178.3 INR

According to Wall Street analysts, the average 1-year price target for AUROPHARMA is 1 178.3 INR with a low forecast of 707 INR and a high forecast of 1 495.2 INR.

What is Aurobindo Pharma Ltd's Revenue forecast?

Projected CAGR

12%

For the last 8 years the compound annual growth rate for Aurobindo Pharma Ltd's revenue is 9%. The projected CAGR for the next 4 years is 12%.

What is Aurobindo Pharma Ltd's Operating Income forecast?

Projected CAGR

21%

For the last 8 years the compound annual growth rate for Aurobindo Pharma Ltd's operating income is 1%. The projected CAGR for the next 4 years is 21%.

What is Aurobindo Pharma Ltd's Net Income forecast?

Projected CAGR

24%

For the last 8 years the compound annual growth rate for Aurobindo Pharma Ltd's net income is 3%. The projected CAGR for the next 4 years is 24%.